US 8067390
Therapeutic targeting of interleukins using siRNA in neutral liposomes
granted A61KA61K45/06A61K9/127
Quick answer
US patent 8067390 (Therapeutic targeting of interleukins using siRNA in neutral liposomes) held by The Board of Regents of the University of Texas System expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K45/06, A61K9/127, A61P, A61P37/06